Apolipoprotein E in Taiwan Chinese patients with dementia

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 4, 2003, Pages 208-211

  Lai, C L ^a   Tai, C T ^a   Lin, S R ^a   Lin, R T ^a   Yang, Y H ^a   Liu, C K ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apolipoprotein E; Chinese; Dementia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE ISOLATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TAIWAN;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; RISK FACTORS; TAIWAN;

EID: 0141616535     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072804     Document Type: Article

References (53)

1. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1998;240:622-630.
2. de Knijft P, van den Maagdenberg AMJM, frants R, Havekes LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994; 4:178-194.
3. Shimano H, Ishibashi S, Murase T, Gotohda T, Yamada N, Fumimaro T, Ohtomo E: Plasma lipoprotein in patients with multi-infarct dementia. Atherosclerosis 1989;79:257-260.
4. Lin RT, Lai CL, Tai CT, Liu CK, Howng SH: Prevalence of Alzheimer's disease and vascular dementia in southern Taiwan: Impact of age, sex, education, and urbanization. J Neurol Sci 1998;160:67-75.
5. Liu CK, Lai CL, Tai CT, Lin RT, Howng S: Incidence and subtypes of dementia in elderly community inhabitants of southern Taiwan: Impacts of socio-demographic factors. Neurology 1998;50:1572-1579.
6. Liu HC, Fuh JL, Wang SJ, Larson EB, Lin KN, Wang HC, Chou P, Wu ZA, Lin CH, Wang PN, Teng EL: Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998;12:127-134.
7. Urakami K, Adachi Y, Wakutani Y, Isoe K, Ji Y, Takahashi K, Nakashima K: Epidemiologic and genetic studies of dementia of the Alzheimer type in Japan. Dement Geriatr Cogn Disord 1998;9:294-298.
8. Farrag A, Farwiz HM, Khedr EH, Mahfouz RM, Omran SM: Prevalence of Alzheimer's disease and other dementing disorders: Assiut-Upper Egypt study. Dement Geriatr Cogn Disord 1998;9:323-328.
9. Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer's type in the Framingham study. Neurology 1992;42:115-119.
10. Hofman A, Rocca WA, Brayne C, Breteler MMB, Clarke M, Cooper B, Copeland JRM, Dartigues JF, Droux ADS, Hagnell O, Heeren TJ, Engedal K, Joker C, Lindesay J, Iobo A, Mann AH, Molsa PK, Morgan K, O'Connor DW, Sulkava R, Kay DWK, Amaducci L, for the EURODEM Prevalence Research Group: The prevalence of dementia in Europe: A collaborative study of 1980-1990 findings. Int J Epidemiol 1991;20:736-748.
11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
12. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H: The apolipoprotein ε4 in patients with Alzheimer's disease. Ann Neurol 1993;34:752-754.
13. Okuizumi K, Onodera O, Tanaka H, Kobayashi H, Tsuji S, Takahachi H, Oyanagi K, Seki K, Tanaka M, Naruse S: ApoE-ε4 and early-onset Alzheimer's. Nat Genet 1994;7:10-11.
14. Kuusisto J, Koivisto K, Kervinen K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Pyorala K, Kesaniemi YA, Riekkinen P, Laakso M: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. BMJ 1994;309:636-638.
15. Isoe K, Urakami K, Sato K, Takahashi K: Apolipoprotein E in patients with dementia of Alzheimer's type and vascular dementia. Acta Neurol Scand 1996;93:133-137.
16. Duara R, Barker WW, Lopez-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, St George-Hyslop PH: Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-1579.
17. Mak YT, Chiu H, Woo J, Kay R, Chan YS, Hui E, Sze KH, Lum C, Kwok T, Pang CP: Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-149.
18. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, Lee KY, Sim CB: ε4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 1996;46: 1749-1751.
19. Katzman R, Zhang MY, Chen PJ, Gu N, Jiang S, Saitoh T, Chen X, Klauber M, Thomas RG, Liu WT, Yu EHS: Effects of apolipoprotein E in dementia and aging in the Shanghai survey of dementia. Neurology 1997;49:779-785.
20. Farrer UA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA 1997;278:1349-1356.
21. Slooter AJC, Cruts M, Kalmijn S, Hofman A, Breteler MMB, Van Broeckhoven C, Van Duijn CM: Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study. Arch Neurol 1998;55:964-968.
22. Breitner JCS, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tshanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A: ApoE-ε4 count predicts age when prevalence of AD increases, then declines. Neurology 1999;53:521-531.
23. Hu CJ, Sung SM, Liu HC, Hsu WC, Lee LS, Lee CC, Tsai CH, Chang JG: Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan. J Neurol Sci 2000;181: 127-131.
24. Kim HC, Kim DK, Choi IJ, Kang KH, Yi SD, Park J, Park YN: Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population. Psychiatry Clin Neurosci 2001;55:115-120.
25. Arboleda GH, Yunis JJ, Pardo R, Gomez CM, Hedmont D, Arango G, Arboleda H: Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimer's disease. Neurosci Lett 2001;305:135-138.
26. Wang PN, Wang SJ, Hong CJ, Liu TT, Fuh JL, Chi CW, Liu CY, Liu HC: Risk factors for Alzheimer's disease: A case-control study. Neuroepidemiology 1997;16:234-240.
27. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G: The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
28. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L: Apolipoprotein E polymorphism in a healthy Swedish population: Variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993; 39:2125-2129.
29. Kao TJ, Tsai KS, Chang CJ, Huang PC: The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population. Atherosclerosis 1995;114: 55-59.
30. Gerdes LU, Klausen LC, Sihm I, Faergeman O: Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
31. Liu HC, Hong CJ, Wang SJ, Fuh JL, Wang PN, Shyu HY, Teng EL: ApoE genotype in relation to AD and cholesterol. Neurology 1999;59: 962-966.
32. Mathew NT, Davis D, Meyer JS, Chandar K: Hyperlipoproteinemia in occlusive cerebrovascular disease. JAMA 1975;232:262-266.
33. Rossner S, Kjelin KG, Mettinger KL, Siden A, Soderstrom CE: Normal serum cholesterol but low HDL-cholesterol concentration in young patients with ischemic cerebrovascular disease. Lancet 1978;i:577-579.
34. Couderc R, Mahieux F, Bailleul S, Fénelon G, Mary R, Fermanian J: Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: A case-control study. Stroke 1993;24:661-664.
35. Kida E, Pluta R, Lossinsky SA, Golabek AA, Choi-Miura NH, Wisniewski HM, Mossakowski MJ: Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoprotein E and J in the brain. Brain Res 1995;674:341-346.
36. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Nakashima K: Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord 1998; 9:243-245.
37. Luthra K, Prasad K, Kumar P, Dwivedi M, Pandey RM, Das N: Apolipoprotein E gene polymorphism in cerebrovascular disease: A case-control study. Clin Genet 2002;62:39-44.
38. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-354.
39. Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E: Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke 2000;31:1263-1268.
40. Yang J, Feng G, Zhang J, Hui Z, Breen G, St. Clair D, He L: Is ApoE gene a risk factor for vascular dementia in Han Chinese? Int J Mol Med 2001;7:217-219.
41. Molero AE, Pino-Ramirez G, Maestre GE: Modulation be age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-varepsilon4 allele in Latin Americans: Findings from the Maracaibo aging study. Neurosci Lett 2001;307: 5-8.
42. Marin DB, Breuer B, Marin ML, Silverman J, Schmeidler J, Greenberg D, Flynn S, Mare M, Lantz M, Neufeld R, Altstiel L, Davis KL, Mohs RC: The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 1998;140:173-180.
43. Barba R, Martinez-Espinosa S, Rodriguex-Garcia E, Pondal M, Vivancos J, Del Ser T: Poststroke dementia: Clinical features and risk factors. Stroke 2000;31:1494-1501.
44. Herbert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MP: Vascular dementia: Incidence and risk factors in the Canadian study of health and aging. Stroke 2000;31: 1487-1493.
45. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage RCR. Lancet 1991;337:1158-1159.
46. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO: Prevalence of Alzheimer's disease in a community population of older person: Higher than previously reported. JAMA 1989;62:2551-2556.
47. Jorm AF, Korten AE, Handeson AS: The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;6: 465-479.
48. Kokmen E, Beard M, Offoed KP, Kurland LF: Prevalence of medically diagnosed dementia in a defined United States Population: Rochester Minnesota, January 1, 1975. Neurology 1989; 39:773-776.
49. O'Connor DW, Pollitt TA, Hyde JB, Fellows JL, Brook CP, Reiss BB, Roth M: The prevalence of dementia a measured by the Cambridge Mental Disorder for the Elderly Examination. Acta Psychiatr Scand 1989;79:190-198.
50. Lin RT, Lai CL, Tai CT, Liu CK, Howng SL: Cranial computed tomography in ischemic stroke patients with and without dementia - A prospective study. Kaohsiung J Med Sci 1998; 14:203-211.
51. Tomlinson BE, Blessed G, Roth M: Observation on the brains of demented old people. J Neurol Sci 1970;11:205-242.
52. Erkinjuntti T, Haltia M, Palo J, Silkava R, Paetau A: Accuracy of clinical diagnosis of vascular dementia: A prospective clinical and postmortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
53. Gorelick PB, Chatterjee A, Dushyant P, Flowerdew G, Follear W, Taber J, Harris Y: Cranial computed tomographic observations in multi-infarct dementia: A controlled study. Stroke 1992;23:804-811.